KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Profit After Tax: 2009-2024

Historic Profit After Tax for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to -$190.6 million.

  • Emergent BioSolutions' Profit After Tax fell 55.40% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 136.35%. This contributed to the annual value of -$190.6 million for FY2024, which is 74.94% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Profit After Tax of -$190.6 million as of FY2024, which was up 74.94% from -$760.5 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Profit After Tax ranged from a high of $305.8 million in FY2020 and a low of -$760.5 million during FY2023.
  • In the last 3 years, Emergent BioSolutions' Profit After Tax had a median value of -$211.6 million in 2022 and averaged -$387.6 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first spiked by 461.10% in 2020, then tumbled by 259.40% in 2023.
  • Emergent BioSolutions' Profit After Tax (Yearly) stood at $305.8 million in 2020, then dropped by 28.22% to $219.5 million in 2021, then plummeted by 196.40% to -$211.6 million in 2022, then plummeted by 259.40% to -$760.5 million in 2023, then surged by 74.94% to -$190.6 million in 2024.